• TAK-242 (Resatorvid): Advanced Strategies for TLR4 Modulatio

  2026-06-04

  Explore TAK-242 (Resatorvid) as a selective TLR4 inhibitor for precise modulation of inflammatory responses. This article delivers a unique protocol-focused perspective, integrating next-generation delivery innovations and critical assay insights for neuroinflammation research.

• Irinotecan (CPT-11): Mechanistic Insights for Colorectal Can

  2026-06-03

  Irinotecan (CPT-11) is a topoisomerase I inhibitor and anticancer prodrug widely used in colorectal cancer research. It acts through DNA damage and apoptosis induction, and exhibits distinct efficacy and toxicity profiles in vitro and in vivo. Recent evidence further clarifies its roles and limitations in preclinical models.

• Ciprofloxacin in Translational AMR Research: Mechanisms and

  2026-06-03

  This thought-leadership article explores the mechanistic underpinnings and strategic deployment of Ciprofloxacin, a research-grade fluoroquinolone antibiotic, in the evolving landscape of antimicrobial resistance (AMR) research. Drawing upon new epidemiological findings in carbapenem-resistant Enterobacter cloacae and advanced laboratory protocols, it delivers actionable guidance for translational researchers, highlights APExBIO’s high-purity compound, and maps the future frontiers of resistance modeling and experimental innovation.

• Azathramycin A: Macrolide Antibiotic Workflows for TB Models

  2026-06-02

  Azathramycin A, a precision macrolide antibiotic, empowers tuberculosis researchers to dissect ribosome-targeting antibacterial mechanisms within Mycobacterium tuberculosis models. This guide translates advanced workflows, troubleshooting, and comparative insights into actionable laboratory strategies, leveraging APExBIO’s trusted compound for next-level antibacterial agent development.

• Z-VDVAD-FMK: Precision Caspase-2 Inhibition in Apoptosis Ass

  2026-06-02

  Z-VDVAD-FMK, or benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone, unlocks high-resolution mapping of caspase-driven apoptosis and mitochondrial pathways. This article details optimized workflows, cross-validates cutting-edge research, and shares troubleshooting tips for reproducible cell death studies.

• Pioglitazone: PPARγ Agonist Protocols for Inflammation & Met

  2026-06-01

  Pioglitazone, a selective PPARγ agonist, enables advanced workflows for dissecting macrophage polarization, insulin resistance mechanisms, and neuroinflammatory pathways. This guide translates the latest reference findings into practical steps, troubleshooting, and actionable parameters for researchers tackling immune-metabolic disease models.

• Cytochalasin B in Cytoskeletal Research: Protocols & Innovat

  2026-06-01

  Cytochalasin B (NSC 107658) stands out as a precision cytoskeletal research tool, uniquely enabling the dissection of actin-dependent cellular mechanisms. This article translates key experimental breakthroughs into actionable workflows, while offering advanced troubleshooting for maximizing reproducibility in cell-based assays.

• Cy3-dCTP: Precision Fluorescent DNA Labeling for Genomic Wor

  2026-05-31

  Cy3-dCTP (Cyanine 3-deoxycytidine triphosphate) empowers highly sensitive, multicolor DNA and cDNA labeling directly during enzymatic synthesis—streamlining probe development for in situ hybridization, microarrays, and advanced genomics. Its robust incorporation efficiency and compatibility with cutting-edge enzymatic strategies make it an indispensable tool for modern molecular biology.

• Synergistic Induction of RCC Cell Death via Lysosomal Permea

  2026-05-30

  The referenced study demonstrates that the DNMT1 inhibitor SGI-1027, when combined with the mTOR inhibitor everolimus, synergistically induces apoptosis and pyroptosis in renal cancer by triggering lysosomal membrane permeability. This mechanistic insight suggests new strategies to overcome drug resistance in advanced renal cell carcinoma and highlights the importance of lysosomal function analysis.

• RESTRICT-seq Reveals KAT6A Inhibition Sensitizes SCC Cells

  2026-05-29

  The referenced study introduces RESTRICT-seq, a time-gated CRISPR screening method, to uncover epigenetic dependencies conferring squamous cell carcinoma (SCC) resistance. Notably, the work identifies KAT6A as a vulnerability and provides a framework for evaluating selective histone acetyltransferase inhibitors such as WM-8014 in oncogene-induced senescence and cell cycle arrest models.

• Nonconventional GLP-1 and Glucagon Receptor Interplay via FR

  2026-05-29

  This study uncovers unexpected cross-reactivity between glucagon and GLP-1 receptors, demonstrating that glucagon can function as a noncanonical GLP-1R agonist. High-throughput FRET assays for cAMP reveal complex agonist and antagonist interactions, challenging established assumptions about receptor specificity and informing future design of peptide tools for metabolic research.

• Toremifene in Breast Cancer: 20 Years of Clinical Insights

  2026-05-28

  This review synthesizes two decades of clinical experience with toremifene, a selective estrogen receptor modulator, for hormone receptor-positive breast cancer. The paper highlights innovations in personalized endocrine therapy, explores biomarker-driven strategies, and contextualizes toremifene’s role relative to steroidal aromatase inhibitors.

• Sulfo-NHS-LC-Biotin: Technical Guide for Protein Biotinylati

  2026-05-28

  Sulfo-NHS-LC-Biotin is a water-soluble reagent designed for covalent biotin labeling of primary amines, especially on cell surface proteins, using fully aqueous protocols. It is not suitable for reversible or intracellular biotinylation workflows, as the reagent is membrane-impermeable and forms irreversible amide bonds.

• Thymoquinone Mitigates Doxorubicin-Induced Cardiotoxicity vi

  2026-05-27

  This study demonstrates, for the first time, that thymoquinone protects against doxorubicin-induced cardiotoxicity in mice by activating the Nrf2/HO-1 antioxidant pathway and reducing ferroptosis in cardiomyocytes. These findings clarify mechanistic links between oxidative stress, iron-mediated cell death, and potential mitigation strategies in anthracycline chemotherapy models.

• 4-Ethylphenyl Sulfate in Gut-Brain and Renal Biomarker Resea

  2026-05-27

  4-Ethylphenyl sulfate (4-EPS) from APExBIO stands out as a high-purity tool for modeling gut microbiota-brain interactions and renal dysfunction. With robust solubility and relevance in both biomarker and behavioral assays, it enables reproducible, translational workflows and advanced biomaterial interface studies.

452 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page